Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data “suggest CoreValve should be preferred option for high-risk patients” -Wayne Batchelor: Closing the data gap -Martin Cowie: SERVE-HF -Profile: Deepak L Bhatt
Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data “suggest CoreValve should be preferred option for high-risk patients” -Wayne Batchelor: Closing the data gap -Martin Cowie: SERVE-HF -Profile: Deepak L Bhatt